Vor Biopharma Inc. · NASDAQ:VOR
Paradigm Biocapital Advisors LP's stake in Vor Biopharma Inc. fell to 4.50% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP's stake in Vor Biopharma Inc. fell to 4.50%, 1,750,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 1,750,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 4.50% | 1,750,000 |
| Paradigm BioCapital Advisors GP LLC | 4.50% | 1,750,000 |
| Senai Asefaw, M.D. | 4.50% | 1,750,000 |
| Paradigm BioCapital International Fund Ltd. | 4.00% | 1,546,061 |
Source
Related
- Vor Biopharma Inc.
- Paradigm Biocapital Advisors LP
- Vor Biopharma Inc. shareholders
- Schedule 13G · Paradigm Biocapital Advisors LP · Nov 18, 2025
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026